Worth Venture Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-43
Closed -$1K 118
2017
Q2
$1K Buy
43
+3
+8% +$70 ﹤0.01% 86
2017
Q1
$1K Buy
+40
New +$1K ﹤0.01% 103